Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients

A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact trac...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Emerg Infect Dis
Päätekijät: Okba, Nisreen M.A., Müller, Marcel A., Li, Wentao, Wang, Chunyan, GeurtsvanKessel, Corine H., Corman, Victor M., Lamers, Mart M., Sikkema, Reina S., de Bruin, Erwin, Chandler, Felicity D., Yazdanpanah, Yazdan, Le Hingrat, Quentin, Descamps, Diane, Houhou-Fidouh, Nadhira, Reusken, Chantal B.E.M., Bosch, Berend-Jan, Drosten, Christian, Koopmans, Marion P.G., Haagmans, Bart L.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Centers for Disease Control and Prevention 2020
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7323511/
https://ncbi.nlm.nih.gov/pubmed/32267220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2607.200841
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia